169 related articles for article (PubMed ID: 32743367)
1. Radiation recall pneumonitis induced by nivolumab in a patient with renal cell carcinoma.
Nakamura K; Okubo K; Takahashi T; Mitsumori K; Ishigaki T; Ohnishi H
IJU Case Rep; 2019 Jan; 2(1):30-33. PubMed ID: 32743367
[TBL] [Abstract][Full Text] [Related]
2. Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapy.
Noda-Narita S; Naito T; Udagawa H; Goto K; Miyawaki T; Mamesaya N; Nakashima K; Kenmotsu H; Shimokawaji T; Kato T; Hakozaki T; Okuma Y; Nakamura M; Nakayama Y; Watanabe H; Kusumoto M; Ohe Y; Horinouchi H
Cancer Sci; 2023 Feb; 114(2):630-639. PubMed ID: 36285515
[TBL] [Abstract][Full Text] [Related]
3. Radiation recall pneumonitis induced by erlotinib after palliative thoracic radiotherapy for lung cancer: Case report and literature review.
Awad R; Nott L
Asia Pac J Clin Oncol; 2016 Mar; 12(1):91-5. PubMed ID: 26846159
[TBL] [Abstract][Full Text] [Related]
4. Late-onset programmed cell death protein-1 inhibitor-induced pneumonitis after cessation of nivolumab or pembrolizumab in patients with advanced non-small cell lung cancer: a case series.
Kimura H; Sone T; Araya T; Murata A; Yamamura K; Ohkura N; Hara J; Abo M; Kasahara K
Transl Lung Cancer Res; 2021 Mar; 10(3):1576-1581. PubMed ID: 33889531
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Radiation Pneumonitis History Before Nivolumab with Onset of Interstitial Lung Disease and Progression-free Survival of Patients with Pre-treated Advanced Non-small Cell Lung Cancer.
Tamiya A; Tamiya M; Nakahama K; Taniguchi Y; Shiroyama T; Isa SI; Inoue T; Okishio K; Nishino K; Kumagai T; Suzuki H; Hirashima T; Imamura F; Atagi S
Anticancer Res; 2017 Sep; 37(9):5199-5205. PubMed ID: 28870955
[TBL] [Abstract][Full Text] [Related]
6. Rapidly progressing programmed cell death 1 inhibitor-related pneumonitis in a hemodialytic patient with metastatic renal cell carcinoma.
Matsumura Y; Iemura Y; Fukui S; Tatsumi Y; Kagebayashi Y; Samma S
IJU Case Rep; 2019 May; 2(3):155-157. PubMed ID: 32743399
[TBL] [Abstract][Full Text] [Related]
7. Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report.
Ye X; Yang J; Stebbing J; Peng L
BMC Pulm Med; 2022 Feb; 22(1):54. PubMed ID: 35123465
[TBL] [Abstract][Full Text] [Related]
8. Pembrolizumab-induced Radiation Recall Pneumonitis After the Resolution of Typical Asymptomatic Radiation Pneumonitis.
Itamura H; Ohguri T; Yahara K; Nakahara S; Kakinouchi S; Morisaki T; Yatera K; Tanaka F; Korogi Y
J UOEH; 2020; 42(3):261-266. PubMed ID: 32879190
[TBL] [Abstract][Full Text] [Related]
9. Improvement in recurring nivolumab-induced pneumonitis with repetitive administration of infliximab in a patient with head and neck cancer: A case report.
Ueno S; Uenomachi M; Kusaba H; Ito M; Suzuki K; Ohmura H; Tsuchihashi K; Ariyama H; Akashi K; Baba E
Mol Clin Oncol; 2021 Oct; 15(4):221. PubMed ID: 34476105
[TBL] [Abstract][Full Text] [Related]
10. Pre-existing interstitial lung disease is associated with onset of nivolumab-induced pneumonitis in patients with solid tumors: a retrospective analysis.
Yamaguchi T; Shimizu J; Hasegawa T; Horio Y; Inaba Y; Hanai N; Muro K; Hida T
BMC Cancer; 2021 Aug; 21(1):924. PubMed ID: 34399710
[TBL] [Abstract][Full Text] [Related]
11. Findings on Chest CT Performed in the Emergency Department in Patients Receiving Immune Checkpoint Inhibitor Therapy: Single-Institution 8-Year Experience in 136 Patients.
Smith DA; Radzinsky E; Tirumani SH; Guler E; Petraszko A; Kikano E; Hoimes CJ; Ramaiya NH
AJR Am J Roentgenol; 2021 Sep; 217(3):613-622. PubMed ID: 33295801
[No Abstract] [Full Text] [Related]
12. Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer.
Cousin F; Desir C; Ben Mustapha S; Mievis C; Coucke P; Hustinx R
Radiother Oncol; 2021 Apr; 157():47-55. PubMed ID: 33453313
[TBL] [Abstract][Full Text] [Related]
13. Radiation Recall Pneumonitis After Treatment With Checkpoint Blockade Immunotherapy: A Case Series and Review of Literature.
Riviere P; Sumner W; Cornell M; Sandhu A; Murphy JD; Hattangadi-Gluth J; Bruggeman A; Kim SS; Randall JM; Sharabi AB
Front Oncol; 2021; 11():662954. PubMed ID: 33996587
[TBL] [Abstract][Full Text] [Related]
14. Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer.
Torresan S; Zussino G; Cortiula F; Follador A; Fasola G; Girometti R; Cereser L
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835802
[TBL] [Abstract][Full Text] [Related]
15. High incidence and early onset of nivolumab-induced pneumonitis: four case reports and literature review.
Koyama N; Iwase O; Nakashima E; Kishida K; Kondo T; Watanabe Y; Takahashi H; Umebayashi Y; Ogawa Y; Miura H
BMC Pulm Med; 2018 Jan; 18(1):23. PubMed ID: 29378571
[TBL] [Abstract][Full Text] [Related]
16. [Successful Treatment of Squamous Cell Lung Cancer without PD-L1 Expression Using Fourth-Line Nivolumab].
Ozawa R; Kuraishi H; Hirota S; Yamamoto M; Masubuchi T; Koyama S; Watanabe M
Gan To Kagaku Ryoho; 2019 May; 46(5):917-920. PubMed ID: 31189815
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer.
Voong KR; Hazell SZ; Fu W; Hu C; Lin CT; Ding K; Suresh K; Hayman J; Hales RK; Alfaifi S; Marrone KA; Levy B; Hann CL; Ettinger DS; Feliciano JL; Peterson V; Kelly RJ; Brahmer JR; Forde PM; Naidoo J
Clin Lung Cancer; 2019 Jul; 20(4):e470-e479. PubMed ID: 31031204
[TBL] [Abstract][Full Text] [Related]
18. [Immune-related pneumonitis caused by programmed death-1 inhibitor Pembrolizumab: a case report and literature review].
Chen YL; Zhao J; Jia R; Wang HY; Zheng J; Bai CQ; Wang MZ; Xu JM
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Oct; 40(10):736-743. PubMed ID: 29050127
[No Abstract] [Full Text] [Related]
19. Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer.
Ding X; Ji W; Li J; Zhang X; Wang L
Radiat Oncol; 2011 Mar; 6():24. PubMed ID: 21375774
[TBL] [Abstract][Full Text] [Related]
20. Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report.
Miyauchi Y; Naito H; Tsunemori H; Tani R; Hasui Y; Miyake Y; Minamino T; Ishikawa R; Kushida Y; Haba R; Sugimoto M
J Med Case Rep; 2021 Oct; 15(1):508. PubMed ID: 34649593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
